Replies to post #28395 on Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

How long have you and FitBit been working together on this board? You guys should know by now we are not phased by your nonsense. You should try somewhere more effective.

[Andy2018]

Aviptadil is the only savior for whole world. All other “therapy” drugs failed for covid critical patients. $RLFTF

[Inelgr]

If these guys are so confident in the results, spin it FFS, so that the pressure is there to move it through the approval process.

"spin it?"

If you think Dr. Javitt is the type of MD/scientist who would "spin" something they are working on, that hasn't received FDA approval yet...for the sake of shareholders, you haven't done your DD on the guy or NeuroRX which of course is responsible for guiding RLF-100 in the U.S.

There's plenty of spin doctors out there for other's in penny land. They need to spin for a reason.

Dr. Javitt isn't a "spin it" kinda guy.

As far as:

Essentially, no one in the US knows about this drug...and people that could live through Covid are dying instead.

Covid has unfortunately become politicized due to the hatred for the U.S. President.

1. Without "operation warp speed," Aviptadil likely wouldn't be as far along the process as it is now (nor many of the other therapeutic/vaccine options).
2. Even if something is rammed through even faster than warp speed as your suggesting, several governors have stated that they will conduct their own reviews prior to allowing the sale/distribution within their states. This will, of course, add delay on top of when any FDA approval is made at the federal level.

Seven jurisdictions indicated they would analyze the data independently: California, Colorado, the District of Columbia, Michigan, New York, Oregon and West Virginia.

https://www.rollcall.com/2020/09/17/exclusive-states-plan-to-independently-vet-covid-19-vaccine-data/

Keeping in mind, that this pertains to the U.S. only. No other country in the world has given Aviptadil (or any other therapeutic that I'm aware of) full approval. When it get's approved, it will most likely be the U.S. that does it first.

The irony here is, since this is a major/serious health crisis, the last thing the gov't should be focused on is "spinning" something to benefit shareholders when they should be concerned with efficacy and safety.

Aviptadil will get there when the clinicians/scientists/fda says it's ready (well in advance of when it would have in years past), and subsequently the stock will raise...just not on any day traders timeline.